News

A clinical trial is underway for the MicroStent microvascular device, which is designed to open occluded arteries and prevent below-the-knee amputations.

Read More

To accelerate study of the MicroStent microvascular device and other new technologies designed to prevent amputation, MMS has assembled six world leaders in treating peripheral artery disease and critical limb ischemia.

Read More

Wilmington, MA April 11, 2018—Micro Medical Solutions (MMS) is positioning itself for growth and product commercialization with the recent addition of two new employees to its organization: Amanda Panos as Vice President, Clinical Affairs, and Sarrah Val as Director of Clinical Affairs. Ms. Panos brings 20 years of experience in the medical device industry, where […]

Read More

Micro Medical Solutions is pleased to announce an organizational change that includes the promotions of three key members of the company’s executive team.

Read More

Wilmington, MA February 10, 2017—Micro Medical Solutions announces it has received European CE Mark approval for the MicroStent, the third of its key innovations to receive CE Mark in the last year.

Read More

Wilmington, MA April 18, 2016—Micro Medical Solutions announces it has received 510K approval for one of its lead products, the MicroBalloon, a key part of its planned Micro Vascular Integrated Platform (mVIP). “The MicroBalloon offers ultra-low profile design and a microfilament wire for maximum push and optimal support,” says Gregory Sullivan, CEO of Micro Medical […]

Read More

Wilmington, MA March 16, 2016—Micro Medical Solutions announces it has received 510K approval for one of its key interventional innovations. “The MicroGuide offers a best-in-class 3Fr design with optimal push, support, and stability with enhanced flexibility for segment-leading device deliverability and support,” says Gregory Sullivan, CEO of Micro Medical Solutions.

Read More

Wilmington, MA March 14, 2016—Micro Medical Solutions announces it has received European CE Mark approval for two of its key innovations. “This approval paves the way for the final stage of development for our proprietary Micro Vascular Integrated Platform,” said Gregory Sullivan, CEO of Micro Medical Solutions.

Read More

Wilmington MA, February 2016—Micro Medical Solutions, a pioneer in interventional innovation in the treatment of critical limb ischemia (CLI), today announced that one of the most respected experts in the treatment of peripheral artery disease (PAD) and CLI, Dr. Jihad Mustapha, M.D., has joined the company as Chief Medical Officer. Dr. Mustapha is a global thought leader for the treatment of patients with CLI, as well as amputation prevention.

Read More

Back To Top